Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021:1341:15-25.
doi: 10.1007/5584_2018_248.

Therapeutic Potential of Adipose Stem Cells

Rachel A Sabol  1   2 , Annie C Bowles  1   3 , Alexandra Côté  1   3 , Rachel Wise  1   4 , Nicholas Pashos  1   5 , Bruce A Bunnell  6   7   8
Affiliations
Review

Therapeutic Potential of Adipose Stem Cells

Rachel A Sabol et al. Adv Exp Med Biol. 2021.

Abstract

Adipose stem cells (ASCs) have gained attention in the fields of stem cells regenerative medicine due to their multifaceted therapeutic capabilities. Promising preclinical evidence of ASCs has supported the substantial interest in the use of these cells as therapy for human disease. ASCs are an adult stem cell resident in adipose tissue with the potential to differentiation along mesenchymal lineages. They also are known to be recruited to sites of inflammation where they exhibit strong immunomodulatory capabilities to promote wound healing and regeneration. ASCs can be isolated from adipose tissue at a relatively high yield compared to their mesenchymal cell counterparts: bone marrow-derived mesenchymal stem cells (BM-MSCs). Like BM-MSCs, ASCs are easily culture expanded and have a reduced immunogenicity or are perhaps immune privileged, making them attractive options for cellular therapy. Additionally, the heterogeneous cellular product obtained after digestion of adipose tissue, called the stromal vascular fraction (SVF), contains ASCs and several populations of stromal and immune cells. Both the SVF and culture expanded ASCs have the potential to be therapeutic in various diseases. This review will focus on the preclinical and clinical evidence of SVF and ASCs, which make them potential candidates for therapy in regenerative medicine and inflammatory disease processes.

Keywords: Adipose stem cells; Mesenchymal stem cells; Regenerative medicine; Stem cell therapy; Stromal vascular fraction.

PubMed Disclaimer

References

    1. Aguirre A, Sancho-Martinez I, Izpisua Belmonte JC (2013) Reprogramming toward heart regeneration: stem cells and beyond. Cell Stem Cell 12(3):275–284 - PubMed - DOI - PMC
    1. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449(7165):1003–1007 - PubMed - PMC - DOI
    1. Bjorninen M, Gilmore K, Pelto J, Seppanen-Kaijansinkko R, Kellomaki M, Miettinen S, Wallace G, Grijpma D, Haimi S (2017) Electrically stimulated adipose stem cells on Polypyrrole-coated scaffolds for smooth muscle tissue engineering. Ann Biomed Eng 45(4):1015–1026 - PubMed - DOI - PMC
    1. Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15(6):641–648 - PubMed - PMC - DOI
    1. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, Jack RS, Wunderlich FT, Bruning JC, Muller W, Rudensky AY (2011) Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34(4):566–578 - PubMed - PMC - DOI

LinkOut - more resources